Clinical Drug Experience Knowledgebase

Antibody-Dependent Cell Cytotoxicity (Phase 1)

Bone Marrow Cells (Phase 1/Phase 2)

Breast Neoplasms (Phase 1/Phase 2)

Carcinoma (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 1/Phase 2)

Colonic Neoplasms (Phase 1/Phase 2)

Drugs, Investigational (Phase 1)

Drug Therapy (Phase 1)

Endometriosis (Phase 1)

Ependymoma (Phase 1)

Esophageal Neoplasms (Phase 1/Phase 2)

Fallopian Tube Neoplasms (Phase 1/Phase 2)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Hamartoma (Phase 1/Phase 2)

Hematologic Neoplasms (Phase 1)

HIV (Phase 2)

Immunotherapy (Phase 1)

Laryngeal Neoplasms (Phase 1/Phase 2)

Leukemia (Phase 1/Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 1)

Leukemia, Megakaryoblastic, Acute (Phase 1/Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 1/Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 1/Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 1/Phase 2)

Liver Neoplasms (Phase 1/Phase 2)

Liver Transplantation (Phase 1/Phase 2)

Lung Neoplasms (Phase 1/Phase 2)

Lymphoma (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Medulloblastoma (Phase 1)

Melanoma (Phase 1)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 1/Phase 2)

Natural Killer T-Cells (Phase 1)

Neoplasms (Phase 2)

Neuroblastoma (Phase 1/Phase 2)

Ovarian Neoplasms (Phase 1/Phase 2)

Pancreatic Neoplasms (Phase 1/Phase 2)

Pneumonia (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)

Prostatic Neoplasms (Phase 1)

Sarcoma (Phase 1/Phase 2)

Small Cell Lung Carcinoma (Phase 2)

T-Lymphocytes (Phase 1/Phase 2)

Tongue Neoplasms (Phase 1/Phase 2)

Uterine Cervical Neoplasms (Phase 1/Phase 2)